Ms. Naoko Shimura and Ms. Nicola Rabson nominated for appointment as new External DirectorsMr. Shinichi Tamura, Mr. Tomohiro Tohyama and Mr.

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a biopharmaceutical company focused on cellular metabolism to treat cancer and rare genetic diseases, announced the upcoming departure of a key board member.

Indivior PLC (LON:INDV), a pharmaceutical company specializing in pharmaceutical preparations with a market capitalization of $2.05 billion, announced the appointment of a new Independent (LON:IOG) ...

Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) signed a SAR 36.1 million revolving short-term credit facility, via its ...

MALMO, SWEDEN / ACCESS Newswire / February 12, 2025 / Ascelia Pharma (STO:ACE) today announces that the Nomination Committee in preparation for the Annual General Meeting (AGM) on 7 May 2025 has been ...

with key implications for public pharmaceutical initiatives For the next week, part of the World Health Organization's (WHO) members are taking part in an Executive Board meeting in Geneva to set the ...

In other developments, Collegium Pharmaceutical expanded its board of directors and appointed Nancy Lurker as a new board member. Lurker's extensive experience includes leadership roles at ...

Collegium Pharmaceutical , Inc. (NASDAQ ... of its board of directors and the appointment of Nancy Lurker as a new board member, effective Tuesday. According to InvestingPro data, the company ...

Kobayashi Pharmaceutical Co. on Feb. 10 posted its first full-year profit decline since going public in 1999 as the health ...

COLL), a pharmaceutical company with a market capitalization of nearly $1 billion and an impressive gross profit margin of 87%, announced on Monday the expansion of its board of directors and the ...